European CHMP recommends approval of use of Flucelvax Tetra in a wider age range

The CHMP has adopted a positive opinion, recommending that its use for the prophylaxis of influenza in adults and children be extended to include children from 2 years of age (currently 9 years).


European Medicines Agency